Role of NLRP3 inflammasome in Bifidobacterium longum-regulated visceral hypersensitivity of postinfectious irritable bowel syndrome

References

• Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KS, McIntire CR, LeBlanc PM, et al. 2010. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity. 32, 367–378.
   PubMed Web of Science ®Google Scholar
• Ford AC, Spiegel BM, Talley NJ, Moayyedi P. 2009. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 7:1279–1286.
   PubMed Web of Science ®Google Scholar
• Horvath A, Dziechciarz P, Szajewska H. 2011. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther. 33:1302–1310.
   PubMed Web of Science ®Google Scholar
• Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, et al. 2007. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 133:24–33.
   PubMed Web of Science ®Google Scholar
• Keating C, Beyak M, Foley S, Singh G, Marsden C, Spiller R, Grundy D. 2008. Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism. J Physiol. 586:4517–4530.
   PubMed Web of Science ®Google Scholar
• Korpela R, Niittynen L. 2012. Probiotics and irritable bowel syndrome. Microb Ecol Health Dis. 23:19–25.
   Google Scholar
• Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, et al. 2009. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 9:95.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Park KS. 2014. Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol. 20:2456–2469.
   PubMed Web of Science ®Google Scholar
• Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, et al. 2005. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 100:373–382.
   PubMed Web of Science ®Google Scholar
• Marshall JK, Thabane M, Borgaonkar MR, James C. 2007. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol. 5:457–460.
   PubMed Web of Science ®Google Scholar
• Ohman L, Simren M. 2013. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep. 15:323.
   PubMedGoogle Scholar
• O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, et al. 2005. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 128:541–551.
   PubMed Web of Science ®Google Scholar
• Pimentel M, Chatterjee S, Chang C, Low K, Song Y, Liu C, et al. 2008. A new rat model links two contemporary theories in irritable bowel syndrome. Digest Dis Sci. 53:982–989.
   PubMed Web of Science ®Google Scholar
• Pimentel M, Chow EJ, Lin HC. 2000. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 95:3503–3506.
   PubMed Web of Science ®Google Scholar
• Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M. 2007. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 56:802–808.
   PubMed Web of Science ®Google Scholar
• Rodes L, Coussa-Charley M, Marinescu D, Paul A, Fakhoury M, Abbasi S, et al. (2013). Design of a novel gut bacterial adhesion model for probiotic applications. Artif Cells Nanomed Biotechnol. 41:116–124.
   PubMed Web of Science ®Google Scholar
• Wang LH, Fang XC, Pan GZ. 2004. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut. 53:1096–1101.
   PubMed Web of Science ®Google Scholar
• Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. 2010. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 32:379–391.
   PubMed Web of Science ®Google Scholar